More studies need to be done, but it appears that something has gone awry in the gut flora of people that’s impacting the symptoms found in chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), Gulf War Illness (GWI), and now, it appears, long COVID. That’s not a surprise. Studies and papers exploring the gut-brain axis abound and make it clear that gut issues can impact the central nervous system and can influence symptoms like fatigue, pain, and sleep.
First, this blog looks at what the gut flora studies have found in ME/CFS, FM, GWI, and long COVID. Then it’s onto a cheap and possibly effective gut flora modifier that might help.
Chronic Fatigue Syndrome (ME/CFS)
A 2018 review concluded that the poor/fair quality and the mixed results of gut microbiome ME/CFS studies indicated there was “currently insufficient evidence for enteric dysbiosis playing a significant role in the pathomechanism of CFS/ME.” Indeed, Hanson’s 2018 study did not find significant evidence of dysbiosis in ME/CFS but Lipkin’s 100-person 2017 study, Hanson’s 2016 study, and a 2013 DeMeirleir study did. So did one of the most interesting and possibly consequential microbiome studies in ME/CFS. A small 2015 study found that exercise produced major changes in the gut microbiome, and problems with leaky gut in ME/CFS but not in healthy controls.
Plus, the 2018 review did not include Lipkin’s 2018 study, which was able to integrate fecal metagenomic data with plasma metabolomic data – thus linking together alterations in the gut with metabolic markers in the blood. Nor did it include the most recent ME/CFS microbiome study – a 105-person Italian study – which found similar results as past microbiome studies: i.e. decreased levels of bacteria from the Firmicutes phylum and increased levels of bacteria from the Bacteroidetes phylum were present.
The authors reported that this shift in gut flora mimics what has been found in autoimmune conditions such as Crohn’s disease, lupus, and diabetes. Interestingly, in the latest study, the alterations in gut flora in both people with ME/CFS and their near relatives were mainly due to increases of the notorious Clostridiales order which contains anaerobic bacteria (oxygen is toxic to them).
Many Clostridiales bacteria are not harmful but the order also includes notably toxic species such as Clostridium difficile and C. botulinum. Intriguingly, the Clostridiales bacteria found decreased in ME/CFS (Lachnospiraceae family) were “good” bacteria that produce butyric acid – an important energy source and gut lining protector. Increasing butyrate production will be a major theme in GWI studies (see below).
Another 2018 review found only two studies that attempted to use probiotics to improve ME/CFS symptoms. Both studies used a single probiotic (Lactobacillus casei strain Shirota, Bifidobacterium infantis 35624) to change the gut composition and both appeared successful in reducing anxiety or inflammatory markers. While the studies were successful, the authors called the evidence that probiotics can influence ME/CFS “limited”.
The gut microbiome hasn’t been studied as well in fibromyalgia, but similar findings have shown up there. A 2004 Pimental study, which unfortunately has not been replicated, found small-bowel bacterial overgrowth in 100% of FM patients, 84% of IBS patients, and only 20% of healthy controls. Pain levels in FM were positively correlated with breath hydrogen levels.
Back in 2008, in a study which one review article did not entirely trust, increased gut permeability was found in both FM and chronic regional pain patients compared to healthy controls. All in all, the results suggest a breakdown in the gut flora in FM has occurred, but a recent Australian review reported that “a paucity of quality research in this area” remains.
Gulf War Illness
Gulf War Illness (GWI) may be on the firmest ground with regard to gut dysbiosis. It’s certainly moved the quickest with regard to testing potential gut treatments. This is presumably because of two overlapping emphases – both of which are missing in ME/CFS and FM. One is the focus from GWI research funders, such as the Department of Defense, on producing treatment options, and the other involves the rapid production of animal models to test potential treatments.
Four years ago, GWI researchers demonstrated that the chemical exposures could cause gut microbiome problems in GWI mice, and that these gut microbiome changes were associated with neuroinflammation as well. Next, GWI researchers demonstrated that butyrate administration improved metabolism, inflammation, fatigue, gastrointestinal problems, etc.
A 2019 placebo-controlled, double-blinded 120-person-plus GWI study, unfortunately, did not find that an antibiotic often used in IBS, called Rifaxmin, was helpful. Another 2019 study found, though – similar to ME/CFS – increased levels of Firmicutes bacteria in GWI. Using the mouse model, a 2019 study suggested that alterations in the gut virome were contributing to leaky gut in GWI.
Gulf War Illness researchers then tried to reverse gut and other problems by using a nutraceutical, derived from the Chinese herb Sparstolonin B (SsnB), to boost butyrate-producing bacteria levels in their mouse model. By restoring the tight gut linings in the mice, SsnB reduced inflammation in the gut and in the central nervous system.
- Numerous studies indicate that the flora or bacteria/viruses in our guts can affect the brain causing fatigue and other problems.
- Studies suggest that an unhealthy, mix of gut flora in ME/CFS, FM, GWI, and long COVID may be contributing to inflammation, leaky gut, and perhaps even neuroinflammation.
- GWI studies that have used herbs and supplements to increase the levels of butyrate-producing bacteria have eliminated leaky gut and reduced inflammation and perhaps even neuroinflammation.
- A recent Stanford study that compared high-fiber and high-protein diets in healthy people found that while high-fiber diets provided some benefits they did not improve microbiome (gut flora) diversity or reduce inflammation.
- The fact that those people on the high-fiber diets who started out with higher levels of microbiome diversity did reduce inflammation suggested that a certain level of gut microbiome diversity is necessary to achieve the full benefits of high fiber diets.
- The people on the fermented foods diets significantly improved their microbiome diversity and reduced their levels of inflammatory markers.Their microbiome diversity slowly improved over time and reached its peak in the last part of the study. The more fermented foods consumed the higher the microbiome diversity reached.
- Note that while the fermented food group ramped up their intake of fermented foods over 4 weeks, they also experienced initial bloating which resolved over time.
- The fact that the same general gut flora factors that had been found depleted in the GWI and ME/CFS studies. improved in the Stanford study suggested that fermented foods might be helpful in these diseases as well.
Finally, this year GWI researchers found that an herbal supplement called Andrographolide not only restored helpful gut bacteria but also helped to correct the gut virome in mice. Leaky gut disappeared, intestinal inflammation declined and appeared to reduce microglial activation as well.
Note that, despite the emphasis on the gut in GWI research, no GWI studies have attempted to improve the gut microbiome using probiotics. Note also that the studies have focused on increasing the levels of the same kind of butyrate-producing bacteria found to be depleted in ME/CFS (butyrate bacteria), and that doing so has been helpful.
The fact that GWI studies are having success using gut modifiers – in GWI mice, for sure – suggests that successful gut modification in GWI (or, for that matter, ME/CFS, FM, or long COVID) may not necessarily entail using probiotics, antibiotics, fiber supplements or diet.
Few long-COVID studies have been done yet, but an oral microbiome study found similar bacterial species to those found in ME/CFS. A review of 4 long-COVID microbiome studies found a loss of microbiome biodiversity, an increase of inflammatory bacteria, decreased anti-inflammatory bacteria, and leaky gut – all of which have been found in ME/CFS. Two studies are underway to study a gut flora modifier called KB109 in long COVID.
It’s good to see new gut treatment options showing up. Recently, an ancient possibility – possibly the most ancient possibility – one which required no special supplements or drugs was tested in healthy controls. A complex Stanford study, “Gut Microbiota-Targeted Diets Modulate Human Immune Status“, explored the role fermented foods can play in returning the gut flora to health. The results were encouraging indeed.
The Stanford Study
The Stanford study used state-of-the-art immune profiling to determine how two dietary interventions – a plant-based fiber diet and a fermented food diet – affected the gut flora and immune functioning in a 17-week randomized, prospective study.
Anyone wishing to try either diet should note that the study contained a 4-week ramp-up phase where the participants gradually increased their fiber/fermented foods intake (“ramp”), followed by a 6-week maintenance phase where they maintained a high level of either fiber or fermented foods (“maintenance”). During the final 4-week choice period, the participants were able to continue their diets as they wished.
Throughout the study, stool samples were assessed for microbiome composition, function, and metabolic output. The blood samples produced a “systems-level view of the immune system”, and included cytokine levels, cell-specific cytokine response signaling, and cell frequency and immune cell signaling at steady-state. In short, this was a heavy-duty study. It was funded by a variety of sources including several foundations, an NIH grant, and a fellowship.
The goal seems to have been to have the participants increase their fiber/fermented intake in a manner of their choosing. They were provided detailed instructions to encourage the two groups to increase their variety of fiber sources (legumes, seeds, whole grains, nuts, vegetables, and fruits) or fermented foods (fermented dairy products, fermented vegetables, fermented non-alcoholic drinks).
The fiber sources were then grouped into fruits, grains, legumes, nuts/seeds, vegetables, meat, dairy, and others for analysis. One serving of fermented foods was defined as: kombucha, yogurt, kefir, buttermilk, kvass = 6 oz; kimchi, sauerkraut, other fermented veggies = 1/4 cup; vegetable brine drink = 2 oz. Broad categories of fermented foods were grouped into cottage cheese, kefir, kombucha, vegetable brine drinks, vegetables, yogurt, other foods, and other drinks.
People in the high-fiber diet arm increased their fiber consumption from an average of 21.5±8.0 g per day (.75 ounces) at baseline to 45.1±10.7 g (1.6 ounces) per day by the end of the maintenance phase (Figure 1C) – about triple the average American intake of fiber/day.
Participants in the high-fermented food diet arm consumed an average of 0.4+0.6 servings per day of fermented food at baseline, which increased to an average of 6.3+2.9 servings per day at the end of the maintenance phase. A New York Times article noted that “one cup of yogurt for breakfast, a 16-ounce bottle of kombucha tea at lunch, and a cup of kimchi at dinner amounts to six daily servings.” The high-fiber group did not increase their fermented food intake and the fermented food group did not increase their fiber intake.
The high-fiber diet group reported an increase in stool softness over time.
Fiber-rich foods provide a good “fermentable” carbon source for the microbiome, but despite the high levels of dietary fiber reached in the high fiber group, microbiome diversity did not increase. Nor did inflammatory markers decrease.
Intriguingly, though, the people on the high-fiber diet who did see a drop in inflammatory markers had a higher microbiome diversity to start off with. That suggested that the people on the high-fiber diet who did not see a drop in inflammatory markers may simply have lacked the bacterial species which fed on the fiber. High levels of undigested carbohydrates in their stools suggested this was so.
That suggests that high-fiber diets may not as beneficial for people who already have a less diverse microbiome, and that finding ways (such as fermentable foods) to increase gut microbiome diversity may be helpful. The gas and bloating that some people experience when adding fiber to their diets may be due to a lack of gut flora diversity.
Fiber enrichment did, however, increase stool microbial protein density, carbohydrate-degrading capacity, and altered short-chain fatty acids.
The High Fermented Foods Group
The fermented food cohort reported bloating during the ramp-up phase which disappeared over time.
In contrast to the high fiber group, microbiome diversity increased over time in the fermented foods group and reached its greatest peak during the last “choice” phase of the study. More was better in this case; the more fermented foods a person ate, the higher their microbial diversity. (Note again that the fermented portion of the diet was slowly increased and some bloating was found at first.)
The bacterial species that increased over time were all in the same Firmicutes phylum which has been found depleted in ME/CFS. Four of the species were found in the Lachnospiraceae family which has also been found depleted in ME/CFS. Interestingly, the new species did not directly come from the fermented foods. Instead, the fermented foods appeared to open the gut flora for the introduction of new bacterial species.
The fermented foods also resulted in a broad dampening of inflammation markers. Nineteen of the 93 cytokines, chemokines, and other inflammatory serum proteins (including some biggies: IL-6, IL-10, and IL-12b) that were assessed during the study decreased significantly. Markers of immune activation also declined.
GWI interventions have largely focused on increasing butyrate levels. The increased butyrate levels found group-wide (but mostly in the high-fiber group) in the study were associated with decreased B-cell frequency – an interesting finding given the role B-cells play in autoimmunity.
The authors called the possibility that a high-fiber/high fermented food diet could synergistically improve both microbiome and immune system functioning “exciting”.
More studies are needed, but gut microbiome studies suggest microbiome diversity is reduced in ME/CFS, with bacteria from the Firmicutes phylum reduced and bacteria from the Bacteroidetes phylum increased. A similar pattern is found in autoimmune diseases as well as Gulf War Illness, where researchers have found that enhancing butyrate bacteria using gut treatments (the Chinese herb Sparstolonin B (SsnB), lacto-N-fucopentaose-III (LNFPIII), Andrographolide) has tightened gut linings and reduced gut inflammation and neuroinflammation. Thus far, the long-COVID gut studies suggest a similar process is occurring there.
A heavy-duty, 16-week Stanford study that compared high fiber and high fermented food diets found that while high fiber diets had some benefits, they did not increase microbiome diversity or impact immune factors. The fact that the participants who had higher baseline levels of microbiome diversity did reduce their inflammatory markers suggested that a diverse gut flora was crucial to achieving the full benefits of a high fiber diet. The bloating and distress some experience on high fiber diets may be due to a lack of gut flora diversity.
On the other hand, the participants on the high fermented food diet did see a significant increase in gut microbiome diversity and did see reductions in inflammatory markers. The more fermented foods the participants incorporated into their diet the greater the increase in gut microbiome diversity that occurred. Interestingly, the same gut flora found to be depleted in ME/CFS and GWI was enhanced by the fermented food diet.
Note that some bloating may be expected as fermented foods are incorporated into one’s diet but this study found that the bloating did disappear over time. People with mast cell activation syndrome (MCAS) may experience problems with fermented foods. That will be covered in the next blog.
- Next up – a review of “The Gut Health Protocol: A Natural Approach to Healing SIBO, Intestinal Candida, GERD, Gastritis and other Gut Health Issues“
Health Rising is Entirely Community Supported.
Please Support Health Rising!
HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT